{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:00:13Z","timestamp":1792202413665,"version":"4.4.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Silent cerebral infarcts (SCIs) are the most common neurological complication in children and adults with sickle cell disease (SCD). In this systematic review, we provide an overview of studies that have detected SCIs in patients with SCD by cerebral magnetic resonance imaging (MRI). We focus on the frequency of SCIs, the risk factors involved in their development and their clinical consequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The databases of Embase, MEDLINE ALL via Ovid, Web of Science Core Collection, Cochrane Central Register of Trials via Wiley and Google Scholar were searched from inception to June 1, 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The search yielded 651 results of which 69 studies met the eligibility criteria. The prevalence of SCIs in patients with SCD ranges from 5.6 to 80.6% with most studies reported in the 20 to 50% range. The pooled prevalence of SCIs in HbSS and HbS\u03b2\n                      <jats:sup>0<\/jats:sup>\n                      SCD patients is 29.5%. SCIs occur more often in patients with the HbSS and HbS\u03b2\n                      <jats:sup>0<\/jats:sup>\n                      genotype in comparison with other SCD genotypes, as SCIs are found in 9.2% of HbSC and HbS\u03b2\n                      <jats:sup>+<\/jats:sup>\n                      patients. Control subjects showed a mean pooled prevalence of SCIs of 9.8%. Data from included studies showed a statistically significant association between increasing mean age of the study population and mean SCI prevalence. Thirty-three studies examined the risk factors for SCIs. The majority of the risk factors show no clear association with prevalence, since more or less equal numbers of studies give evidence for and against the causal association.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis shows SCIs are common in patients with SCD. No clear risk factors for their development were identified. Larger, prospective and controlled clinical, neuropsychological and neuroimaging studies are needed to understand how SCD and SCIs affect cognition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-01864-8","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T21:02:40Z","timestamp":1608584560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1152-7361","authenticated-orcid":false,"given":"Maite E.","family":"Houwing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena L.","family":"Grohssteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein H. G.","family":"Dremmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdows","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichor M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P. J.","family":"de Pagter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michel","family":"Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya J. H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike W.","family":"Vernooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"issue":"9861","key":"1864_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142\u201351.","journal-title":"Lancet."},{"issue":"14","key":"1864_CR2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/S0021-9258(17)40154-2","volume":"252","author":"CA Marotta","year":"1977","unstructured":"Marotta CA, Forget BG, Cohne-Solal M, Wilson JT, Weissman SM. Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA. J Biol Chem. 1977;252(14):5019\u201331.","journal-title":"J Biol Chem"},{"issue":"1","key":"1864_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029786","volume":"7","author":"KI Ataga","year":"2012","unstructured":"Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, et al. Association of coagulation activation with clinical complications in sickle cell disease. PLoS One. 2012;7(1):e29786.","journal-title":"PLoS One"},{"issue":"24","key":"1864_CR4","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","volume":"122","author":"D Manwani","year":"2013","unstructured":"Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood. 2013;122(24):3892\u20138.","journal-title":"Blood."},{"issue":"7","key":"1864_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","volume":"127","author":"MR DeBaun","year":"2016","unstructured":"DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016;127(7):829\u201338.","journal-title":"Blood."},{"issue":"3","key":"1864_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2141.2009.07753.x","volume":"146","author":"JL Kwiatkowski","year":"2009","unstructured":"Kwiatkowski JL, Zimmerman RA, Pollock AN, Seto W, Smith-Whitley K, Shults J, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146(3):300\u20135.","journal-title":"Br J Haematol"},{"issue":"20","key":"1864_CR7","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","volume":"119","author":"MR DeBaun","year":"2012","unstructured":"DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587\u201396.","journal-title":"Blood."},{"issue":"5","key":"1864_CR8","first-page":"965","volume":"17","author":"FG Moser","year":"1996","unstructured":"Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17(5):965\u201372.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1864_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/08880010903360367","volume":"27","author":"JF Casella","year":"2010","unstructured":"Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN, et al. Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol. 2010;27(2):69\u201389.","journal-title":"Pediatr Hematol Oncol"},{"issue":"8","key":"1864_CR10","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1182\/blood.V99.8.3014","volume":"99","author":"CH Pegelow","year":"2002","unstructured":"Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014\u20138.","journal-title":"Blood."},{"issue":"3","key":"1864_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1067\/mpd.2001.117580","volume":"139","author":"ST Miller","year":"2001","unstructured":"Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385\u201390.","journal-title":"J Pediatr"},{"issue":"6 Pt 1","key":"1864_CR12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1542\/peds.97.6.864","volume":"97","author":"FD Armstrong","year":"1996","unstructured":"Armstrong FD, Thompson RJ Jr, Wang W, Zimmerman R, Pegelow CH, Miller S, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97(6 Pt 1):864\u201370.","journal-title":"Pediatrics."},{"issue":"7","key":"1864_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","volume":"6","author":"SE Vermeer","year":"2007","unstructured":"Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611\u20139.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1864_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033\u201348.","journal-title":"JAMA."},{"issue":"10","key":"1864_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jama.2014.11103","volume":"312","author":"MR DeBaun","year":"2014","unstructured":"DeBaun MR. The challenge of creating an evidence-based guideline for sickle cell disease. Jama. 2014;312(10):1004\u20135.","journal-title":"Jama."},{"issue":"8","key":"1864_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1401731","volume":"371","author":"MR DeBaun","year":"2014","unstructured":"DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):699\u2013710.","journal-title":"N Engl J Med"},{"key":"1864_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"issue":"3","key":"1864_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4997\/JRCPE.2017.313","volume":"47","author":"K Forbes","year":"2017","unstructured":"Forbes K. MRI brain white matter change: spectrum of change - how we can grade? J R Coll Physicians Edinb. 2017;47(3):271\u20135.","journal-title":"J R Coll Physicians Edinb"},{"issue":"4","key":"1864_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1182\/blood-2010-12-326298","volume":"118","author":"MR Abboud","year":"2011","unstructured":"Abboud MR, Yim E, Musallam KM, Adams RJ, Investigators SIS. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011;118(4):894\u20138.","journal-title":"Blood."},{"issue":"1","key":"1864_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.advms.2013.09.001","volume":"59","author":"M Arkuszewski","year":"2014","unstructured":"Arkuszewski M, Krejza J, Chen R, Ichord R, Kwiatkowski JL, Bilello M, et al. Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke. Adv Med Sci. 2014;59(1):108\u201313.","journal-title":"Adv Med Sci"},{"issue":"1","key":"1864_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/pbc.24758","volume":"61","author":"A Asbeutah","year":"2014","unstructured":"Asbeutah A, Gupta R, Al-Saeid O, Ashebu S, Al-Sharida S, Mullah-Ali A, et al. Transcranial Doppler and brain MRI in children with sickle cell disease and high hemoglobin F levels. Pediatr Blood Cancer. 2014;61(1):25\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1864_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.20790","volume":"59","author":"T Baldeweg","year":"2006","unstructured":"Baldeweg T, Hogan AM, Saunders DE, Telfer P, Gadian DG, Vargha-Khadem F, et al. Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol. 2006;59(4):662\u201372.","journal-title":"Ann Neurol"},{"issue":"4","key":"1864_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","volume":"117","author":"F Bernaudin","year":"2011","unstructured":"Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011;117(4):1130\u201340 quiz 436.","journal-title":"Blood."},{"issue":"21","key":"1864_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.V116.21.269.269","volume":"116","author":"PMK de Blank","year":"2010","unstructured":"de Blank PMK, Hayward DM, Zimmerman MDR, Pollock A, Kwiatkowski JL. Transcranial Doppler ultrasound velocity, cerebral vasculopathy, and silent infarcts in sickle cell disease. Blood. 2010;116(21):269.","journal-title":"Blood"},{"issue":"Suppl 1","key":"1864_CR25","first-page":"3532","volume":"130","author":"V Brousse","year":"2017","unstructured":"Brousse V, Gr\u00e9vent D, Arnaud C, Kamden A, Kossorotoff M, De Montalembert M, et al. Silent cerebral infarct pathophysiology study in sickle cell anemia children by a multimodal approach. Blood. 2017;130(Suppl 1):3532.","journal-title":"Blood"},{"issue":"7","key":"1864_CR26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jpepsy\/25.7.503","volume":"25","author":"RT Brown","year":"2000","unstructured":"Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol. 2000;25(7):503\u201313.","journal-title":"J Pediatr Psychol"},{"issue":"26","key":"1864_CR27","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1182\/bloodadvances.2017005504","volume":"1","author":"D Calvet","year":"2017","unstructured":"Calvet D, Tuilier T, Mele N, Turc G, Habibi A, Abdallah NA, et al. Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease. Blood Adv. 2017;1(26):2503\u20139.","journal-title":"Blood Adv"},{"issue":"7","key":"1864_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/brain.2016.0474","volume":"7","author":"J Coloigner","year":"2017","unstructured":"Coloigner J, Phlypo R, Coates TD, Lepore N, Wood JC. Graph lasso-based test for evaluating functional brain connectivity in sickle cell disease. Brain Connect. 2017;7(7):443\u201353.","journal-title":"Brain Connect"},{"issue":"19","key":"1864_CR29","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1182\/blood-2012-01-406314","volume":"120","author":"MM Dowling","year":"2012","unstructured":"Dowling MM, Quinn CT, Plumb P, Rogers ZR, Rollins NK, Koral K, et al. Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease. Blood. 2012;120(19):3891\u20137.","journal-title":"Blood."},{"issue":"Suppl 1","key":"1864_CR30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood.V130.Suppl_1.757.757","volume":"130","author":"AL Ford","year":"2017","unstructured":"Ford AL, Fields ME, Guilliams KP, Ragan DK, Yasheng C, Guillaume G, et al. Increased volume and distinct pattern of silent cerebral infarcts in healthy, young adults with sickle cell trait. Blood. 2017;130(Suppl 1):757.","journal-title":"Blood"},{"issue":"16","key":"1864_CR31","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1182\/blood-2018-04-841247","volume":"132","author":"AL Ford","year":"2018","unstructured":"Ford AL, Ragan DK, Fellah S, Binkley MM, Fields ME, Guilliams KP, et al. Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. Blood. 2018;132(16):1714\u201323.","journal-title":"Blood."},{"issue":"5","key":"1864_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/08880010802107497","volume":"25","author":"JI Gold","year":"2008","unstructured":"Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008;25(5):409\u201321.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"1864_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1182\/blood-2014-10-605964","volume":"125","author":"KP Guilliams","year":"2015","unstructured":"Guilliams KP, Fields ME, Hulbert ML. Higher-than-expected prevalence of silent cerebral infarcts in children with hemoglobin SC disease. Blood. 2015;125(2):416\u20137.","journal-title":"Blood."},{"issue":"1","key":"1864_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajh.21901","volume":"86","author":"E Gyang","year":"2011","unstructured":"Gyang E, Yeom K, Hoppe C, Partap S, Jeng M. Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease. Am J Hematol. 2011;86(1):104\u20136.","journal-title":"Am J Hematol"},{"issue":"3","key":"1864_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/ijri.IJRI_166_17","volume":"28","author":"P Issar","year":"2018","unstructured":"Issar P, Nehra M, Singh G, Issar SK. Conventional and advanced brain MR imaging in patients with sickle cell anemia. Indian J Radiol Imaging. 2018;28(3):305\u201311.","journal-title":"Indian J Radiol Imaging"},{"issue":"16","key":"1864_CR36","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood-2016-01-694562","volume":"127","author":"AA Kassim","year":"2016","unstructured":"Kassim AA, Pruthi S, Day M, Rodeghier M, Gindville MC, Brodsky MA, et al. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood. 2016;127(16):2038\u201340.","journal-title":"Blood."},{"issue":"6","key":"1864_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3915","volume":"31","author":"JM Kawadler","year":"2018","unstructured":"Kawadler JM, Hales PW, Barker S, Cox TCS, Kirkham FJ, Clark CA. Cerebral perfusion characteristics show differences in younger versus older children with sickle cell anaemia: results from a multiple-inflow-time arterial spin labelling study. NMR Biomed. 2018;31(6):e3915.","journal-title":"NMR Biomed"},{"issue":"2","key":"1864_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1620\/tjem.209.135","volume":"209","author":"I Melek","year":"2006","unstructured":"Melek I, Akgul F, Duman T, Yalcin F, Gali E. Neurological soft signs as the stroke risk in sickle cell disease. Tohoku J Exp Med. 2006;209(2):135\u201340.","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"1864_CR39","first-page":"150","volume":"154","author":"E Mercuri","year":"1995","unstructured":"Mercuri E, Faundez JC, Roberts I, Flora S, Bouza H, Cowan F, et al. Neurological \u2018soft\u2019 signs may identify children with sickle cell disease who are at risk for stroke. Eur J Pediatr. 1995;154(2):150\u20136.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"1864_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1148\/radiol.2272020903","volume":"227","author":"KO Kader","year":"2003","unstructured":"Kader KO, Xavier G, Francesca BP, Catherine AF, Nevada W, Rebecca I, et al. Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology. 2003;227(2):567\u201374.","journal-title":"Radiology."},{"issue":"1","key":"1864_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.permed.2012.02.006","volume":"1","author":"A Onofri","year":"2012","unstructured":"Onofri A, Montanaro M, Rampazzo P, Colombatti R, Farina FM, Manara R, et al. Intellectual impairment and TCD evaluation in children with sickle cell disease and silent stroke. Perspectives Med. 2012;1(1):272\u20134.","journal-title":"Perspectives Med"},{"issue":"12","key":"1864_CR42","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1001\/archneur.58.12.2017","volume":"58","author":"CH Pegelow","year":"2001","unstructured":"Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001;58(12):2017\u201321.","journal-title":"Arch Neurol"},{"issue":"1","key":"1864_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2013.576","volume":"70","author":"CT Quinn","year":"2013","unstructured":"Quinn CT, McKinstry RC, Dowling MM, Ball WS, Kraut MA, Casella JF, et al. Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurol. 2013;70(1):58\u201365.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1864_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S1355617706060085","volume":"12","author":"J Schatz","year":"2006","unstructured":"Schatz J, Buzan R. Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning. J Int Neuropsychol Soc. 2006;12(1):24\u201333.","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"1864_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1148\/radiology.189.2.8105505","volume":"189","author":"JJ Seibert","year":"1993","unstructured":"Seibert JJ, Miller SF, Kirby RS, Becton DL, James CA, Glasier CM, et al. Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US--correlation with MR imaging and MR angiography. Radiology. 1993;189(2):457\u201366.","journal-title":"Radiology."},{"issue":"7","key":"1864_CR46","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1161\/STROKEAHA.108.537415","volume":"40","author":"GS Silva","year":"2009","unstructured":"Silva GS, Vicari P, Figueiredo MS, Carrete H Jr, Idagawa MH, Massaro AR. Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings. Stroke. 2009;40(7):2408\u201312.","journal-title":"Stroke."},{"issue":"1","key":"1864_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/hr.2013.e3","volume":"5","author":"E Solomou","year":"2013","unstructured":"Solomou E, Kraniotis P, Kourakli A, Petsas T. Extent of silent cerebral infarcts in adult sickle-cell disease patients on magnetic resonance imaging: is there a correlation with the clinical severity of disease? Hematol Rep. 2013;5(1):8\u201312.","journal-title":"Hematol Rep"},{"issue":"1","key":"1864_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1148\/radiol.2281020943","volume":"228","author":"RG Steen","year":"2003","unstructured":"Steen RG, Emudianughe T, Hankins GM, Wynn LW, Wang WC, Xiong X, et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology. 2003;228(1):216\u201325.","journal-title":"Radiology."},{"issue":"7","key":"1864_CR49","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3324\/haematol.2018.187815","volume":"103","author":"S Tewari","year":"2018","unstructured":"Tewari S, Renney G, Brewin J, Gardner K, Kirkham F, Inusa B, et al. Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction. Haematologica. 2018;103(7):1136\u201342.","journal-title":"Haematologica."},{"issue":"4","key":"1864_CR50","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3324\/haematol.2018.206094","volume":"104","author":"L Vaclavu","year":"2019","unstructured":"Vaclavu L, Meynart BN, Mutsaerts H, Petersen ET, Majoie C, VanBavel ET, et al. Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease. Haematologica. 2019;104(4):690\u20139.","journal-title":"Haematologica."},{"issue":"3\u20134","key":"1864_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000373917","volume":"39","author":"V van der Land","year":"2015","unstructured":"van der Land V, Zwanenburg JJ, Fijnvandraat K, Biemond BJ, Hendrikse J, Mutsaerts HJ, et al. Cerebral lesions on 7 tesla MRI in patients with sickle cell anemia. Cerebrovasc Dis. 2015;39(3\u20134):181\u20139.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"1864_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/bjh.13819","volume":"172","author":"V van der Land","year":"2016","unstructured":"van der Land V, Mutsaerts HJ, Engelen M, Heijboer H, Roest M, Hollestelle MJ, et al. Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease. Br J Haematol. 2016;172(2):274\u201384.","journal-title":"Br J Haematol"},{"issue":"18","key":"1864_CR53","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1001\/jama.2010.562","volume":"303","author":"EP Vichinsky","year":"2010","unstructured":"Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. Jama. 2010;303(18):1823\u201331.","journal-title":"Jama."},{"issue":"6","key":"1864_CR54","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S0022-3476(98)70397-X","volume":"132","author":"WC Wang","year":"1998","unstructured":"Wang WC, Langston JW, Steen RG, Wynn LW, Mulhern RK, Wilimas JA, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr. 1998;132(6):994\u20138.","journal-title":"J Pediatr"},{"issue":"5","key":"1864_CR55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/pbc.21612","volume":"51","author":"WC Wang","year":"2008","unstructured":"Wang WC, Pavlakis SG, Helton KJ, McKinstry RC, Casella JF, Adams RJ, et al. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer. 2008;51(5):643\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"1864_CR56","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1469-8749.1998.tb15412.x","volume":"40","author":"KE Watkins","year":"1998","unstructured":"Watkins KE, Hewes DK, Connelly A, Kendall BE, Kingsley DP, Evans JE, et al. Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. Dev Med Child Neurol. 1998;40(8):536\u201343.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"1864_CR57","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.20104","volume":"55","author":"DI Zafeiriou","year":"2004","unstructured":"Zafeiriou DI, Prengler M, Gombakis N, Kouskouras K, Economou M, Kardoulas A, et al. Central nervous system abnormalities in asymptomatic young patients with S\u03b2-thalassemia. Ann Neurol. 2004;55(6):835\u20139.","journal-title":"Ann Neurol"},{"issue":"10","key":"1864_CR58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1182\/blood-2014-09-599852","volume":"125","author":"F Bernaudin","year":"2015","unstructured":"Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Vasile M, Kasbi F, et al. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood. 2015;125(10):1653\u201361.","journal-title":"Blood."},{"issue":"1","key":"1864_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bjh.13525","volume":"171","author":"MI Cancio","year":"2015","unstructured":"Cancio MI, Helton KJ, Schreiber JE, Smeltzer MP, Kang G, Wang WC. Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke. Br J Haematol. 2015;171(1):120\u20139.","journal-title":"Br J Haematol"},{"issue":"1","key":"1864_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.permed.2012.02.046","volume":"1","author":"FM Farina","year":"2012","unstructured":"Farina FM, Rampazzo P, Sainati L, Manara R, Onofri A, Colombatti R, et al. Transcranial Doppler sonography in children with sickle cell disease and silent ischemic lesions. Perspectives Med. 2012;1(1):269\u201371.","journal-title":"Perspectives Med"},{"issue":"6","key":"1864_CR61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ajh.25085","volume":"93","author":"LC Jordan","year":"2018","unstructured":"Jordan LC, Roberts Williams DO, Rodeghier MJ, Covert Greene BV, Ponisio MR, Casella JF, et al. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes. Am J Hematol. 2018;93(6):760\u20138.","journal-title":"Am J Hematol"},{"issue":"1","key":"1864_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/08830738060210010701","volume":"21","author":"MC Kral","year":"2006","unstructured":"Kral MC, Brown RT, Cur\u00e9 JK, Besenski N, Jackson SM, Abboud MR. Radiographic predictors of neurocognitive functioning in pediatric sickle cell disease. J Child Neurol. 2006;21(1):37\u201344.","journal-title":"J Child Neurol"},{"issue":"3","key":"1864_CR63","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bjh.12034","volume":"159","author":"M Thangarajh","year":"2012","unstructured":"Thangarajh M, Yang G, Fuchs D, Ponisio MR, McKinstry RC, Jaju A, et al. Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Br J Haematol. 2012;159(3):352\u20139.","journal-title":"Br J Haematol"},{"issue":"4","key":"1864_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00043426-200007000-00010","volume":"22","author":"WC Wang","year":"2000","unstructured":"Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000;22(4):335\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1864_CR65","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jmri.23505","volume":"35","author":"S Gevers","year":"2012","unstructured":"Gevers S, Nederveen AJ, Fijnvandraat K, van den Berg SM, van Ooij P, Heijtel DF, et al. Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease. J Magn Reson Imaging. 2012;35(4):779\u201387.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1864_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pbc.21745","volume":"52","author":"KJ Helton","year":"2009","unstructured":"Helton KJ, Paydar A, Glass J, Weirich EM, Hankins J, Li C-S, et al. Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia. Pediatr Blood Cancer. 2009;52(1):85\u201391.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1864_CR67","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ajh.10376","volume":"73","author":"R Marouf","year":"2003","unstructured":"Marouf R, Gupta R, Haider MZ, Adekile AD. Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol. 2003;73(4):240\u20133.","journal-title":"Am J Hematol"},{"issue":"2","key":"1864_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bjh.14235","volume":"175","author":"KA Nottage","year":"2016","unstructured":"Nottage KA, Ware RE, Aygun B, Smeltzer M, Kang G, Moen J, et al. Hydroxycarbamide treatment and brain MRI\/MRA findings in children with sickle cell anaemia. Br J Haematol. 2016;175(2):331\u20138.","journal-title":"Br J Haematol"},{"issue":"5","key":"1864_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/088307380001500510","volume":"15","author":"F Bernaudin","year":"2000","unstructured":"Bernaudin F, Verlhac S, Freard F, Roudot-Thoraval F, Benkerrou M, Thuret I, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15(5):333\u201343.","journal-title":"J Child Neurol"},{"issue":"16","key":"1864_CR70","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","volume":"119","author":"MR DeBaun","year":"2012","unstructured":"DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, et al. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood. 2012;119(16):3684\u201390.","journal-title":"Blood."},{"issue":"8","key":"1864_CR71","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1212\/WNL.0000000000006047","volume":"91","author":"LC Jordan","year":"2018","unstructured":"Jordan LC, Kassim AA, Donahue MJ, Juttukonda MR, Pruthi S, Davis LT, et al. Silent infarct is a risk factor for infarct recurrence in adults with sickle cell anemia. Neurology. 2018;91(8):e781\u2013e4.","journal-title":"Neurology."},{"issue":"3","key":"1864_CR72","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1542\/peds.103.3.640","volume":"103","author":"TR Kinney","year":"1999","unstructured":"Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999;103(3):640\u20135.","journal-title":"Pediatrics."},{"issue":"1","key":"1864_CR73","doi-asserted-by":"publisher","first-page":"e26767","DOI":"10.1002\/pbc.26767","volume":"65","author":"FJ Ogunsile","year":"2018","unstructured":"Ogunsile FJ, Currie KL, Rodeghier M, Kassim A, DeBaun MR, Sharma D. History of parvovirus B19 infection is associated with silent cerebral infarcts. Pediatr Blood Cancer. 2018;65(1):e26767.","journal-title":"Pediatr Blood Cancer."},{"issue":"22","key":"1864_CR74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood.V114.22.262.262","volume":"114","author":"SA Sarnaik","year":"2009","unstructured":"Sarnaik SA, Casella JF, Barton BA, Afif M, Airewele G, Berman BW, et al. Elevated systolic blood pressure and low fetal hemoglobin are risk factors for silent cerebral infarcts in children with sickle cell anemia. Blood. 2009;114(22):262.","journal-title":"Blood"},{"issue":"22","key":"1864_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood.V114.22.259.259","volume":"114","author":"JJ Strouse","year":"2009","unstructured":"Strouse JJ, Kraut M, Williams LM, DeBaun MR, Casella JF. Low levels of apolipoprotein A1 are associated with silent cerebral infarcts in children with sickle cell disease. Blood. 2009;114(22):259.","journal-title":"Blood"},{"issue":"3","key":"1864_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1067\/mpd.2001.116935","volume":"139","author":"W Wang","year":"2001","unstructured":"Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391\u20137.","journal-title":"J Pediatr"},{"issue":"4","key":"1864_CR77","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.13179","volume":"168","author":"V van der Land","year":"2015","unstructured":"van der Land V, Hijmans CT, de Ruiter M, Mutsaerts HJMM, Cnossen MH, Engelen M, et al. Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. Br J Haematol. 2015;168(4):553\u20136.","journal-title":"Br J Haematol"},{"issue":"2","key":"1864_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/08830738050200020301","volume":"20","author":"RG Steen","year":"2005","unstructured":"Steen RG, Fineberg-Buchner C, Hankins G, Weiss L, Prifitera A, Mulhern RK. Cognitive deficits in children with sickle cell disease. J Child Neurol. 2005;20(2):102\u20137.","journal-title":"J Child Neurol"},{"issue":"7","key":"1864_CR79","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/dmcn.13113","volume":"58","author":"JM Kawadler","year":"2016","unstructured":"Kawadler JM, Clayden JD, Clark CA, Kirkham FJ. Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Dev Med Child Neurol. 2016;58(7):672\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"1864_CR80","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/jpepsy\/27.8.739","volume":"27","author":"J Schatz","year":"2002","unstructured":"Schatz J, Finke RL, Kellett JM, Kramer JH. Cognitive functioning in children with sickle cell disease: a meta-analysis. J Pediatr Psychol. 2002;27(8):739\u201348.","journal-title":"J Pediatr Psychol"},{"issue":"4","key":"1864_CR81","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1467-7687.2006.00503.x","volume":"9","author":"AM Hogan","year":"2006","unstructured":"Hogan AM, Pit-ten Cate IM, Vargha-Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci. 2006;9(4):379\u201387.","journal-title":"Dev Sci"},{"key":"1864_CR82","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12916-014-0119-0","volume":"12","author":"JP Fanning","year":"2014","unstructured":"Fanning JP, Wong AA, Fraser JF. The epidemiology of silent brain infarction: a systematic review of population-based cohorts. BMC Med. 2014;12:119.","journal-title":"BMC Med"},{"issue":"10","key":"1864_CR83","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1161\/STROKEAHA.114.006110","volume":"45","author":"MC Caughey","year":"2014","unstructured":"Caughey MC, Loehr LR, Key NS, Derebail VK, Gottesman RF, Kshirsagar AV, et al. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study. Stroke. 2014;45(10):2863\u20137.","journal-title":"Stroke."},{"key":"1864_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eclinm.2019.05.003","volume":"11","author":"CR Cahill","year":"2019","unstructured":"Cahill CR, Leach JM, McClure LA, Irvin MR, Zakai NA, Naik R, et al. Sickle cell trait and risk of cognitive impairment in African-Americans: the REGARDS cohort. EClinicalMedicine. 2019;11:27\u201333.","journal-title":"EClinicalMedicine."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01864-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T03:34:41Z","timestamp":1670470481000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01864-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01864-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable (NA)","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.H. Cnossen has received investigator-initiated research and travel grants over the years from the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Dutch \u2018Innovatiefonds Zorgverzekeraars\u2019, Pfizer, Baxter\/Baxalta\/Shire, Bayer Schering Pharma, CSL Behring, Sobi, Novo Nordisk, Novartis and Nordic Pharma and has served as a steering board member for Roche and Bayer. All grants, awards and fees go to the institution. P.J. de Pagter has received a grant from Rotary Foundation for the institution. All other authors declare no conflicts of interest relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"393"}}